Carregant...
66 High Cost Drug Policies in Canadian Children’s Hospitals
BACKGROUND: Over the past decade a number of highly promising new therapeutic entities have become available. Many of these new treatments are biologicals or antibodies rather than conventional small molecules. These drugs offer great promise but come with the potential for potent adverse effects as...
Guardat en:
| Publicat a: | Paediatr Child Health |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6543435/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/pch/pxz066.065 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|